These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A Puszko AK; Sosnowski P; Pułka-Ziach K; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Bioorg Med Chem Lett; 2019 Sep; 29(17):2493-2497. PubMed ID: 31326342 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance. Puszko AK; Sosnowski P; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Bioorg Med Chem; 2023 Oct; 94():117482. PubMed ID: 37774449 [TBL] [Abstract][Full Text] [Related]
4. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity. Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A Masłowska K; Witkowska E; Tymecka D; Halik PK; Misicka A; Gniazdowska E Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056995 [TBL] [Abstract][Full Text] [Related]
6. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation. Sabki A; Khelifi L; Kameli A; Baali S Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050 [TBL] [Abstract][Full Text] [Related]
7. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine. Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142 [TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272 [TBL] [Abstract][Full Text] [Related]
9. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity. Teran M; Nugent MA J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342 [TBL] [Abstract][Full Text] [Related]
10. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1. Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638 [TBL] [Abstract][Full Text] [Related]
11. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1. Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269 [TBL] [Abstract][Full Text] [Related]